Celix-200

Quick links to important sections

Celix-200

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Celix-200

Celix-200: A Comprehensive Overview

Property Description
Active ingredient Celecoxib
Form Hard Capsule (Oral Dosage Form)
Pharmacological class Selective Cyclooxygenase-2 (COX-2) Inhibitor
Common use Pain and Inflammation Relief
Origin Synthetic Organic Compound
Status Prescription-only (Rx)

What Type of Medicine is Celix-200?

Celix-200 is a prescription-only pharmaceutical product that utilizes the active ingredient celecoxib, primarily indicated for systemic use against symptoms of pain and inflammation. It belongs to the pharmacological category of Nonsteroidal Anti-inflammatory Drugs (NSAIDs), but is uniquely classified as a selective Cyclooxygenase-2 (COX-2) inhibitor, a designation placing it within the specialized subclass of coxibs. This medication is consistently manufactured as a hard capsule for oral administration, a feature that defines its delivery method within the market.

Celix-200's Selective Composition and Origin

The core component, celecoxib, is a synthetic organic compound defined chemically as a diaryl-substituted pyrazole containing a sulfonamide moiety. Pharmacological studies confirm that celecoxib's anti-inflammatory properties are supported by research, with its distinguishing feature being its mechanism of selective inhibition of the COX-2 enzyme. This selective action means the drug preferentially blocks the enzyme responsible for inflammatory signals while exhibiting comparative avoidance of the protective COX-1 enzyme, thereby defining its distinct safety profile compared to non-selective NSAIDs.

General Purpose: Pain and Inflammation Relief

The therapeutic focus of Celix-200 is the provision of effective pain relief and reduction of inflammation relief associated with various conditions. By specifically limiting the inflammatory chemical pathways—the generation of prostaglandins—the medication delivers its intended analgesic and anti-inflammatory benefits to the patient.

What side effects are possible with Celix-200?

Celix-200 (Celecoxib) is a nonsteroidal anti-inflammatory drug (NSAID) that is generally well-tolerated, but like all medications, it can cause side effects. Patients should be aware of both common and serious potential adverse effects.

Common Side Effects

The most common side effects are typically gastrointestinal and may include abdominal pain, diarrhea, indigestion (dyspepsia), and gas (flatulence). Other common effects may be dizziness, headache, and symptoms of an upper respiratory tract infection (e.g., sore throat, runny nose).


Serious Warnings and Adverse Events

Celix-200 carries a boxed warning regarding serious risks:

  • Cardiovascular Risk: NSAIDs, including Celix-200, increase the risk of serious cardiovascular thrombotic events, such as myocardial infarction (heart attack) and stroke, which can be fatal. This risk may increase with duration of use and in those with pre-existing heart disease. It should not be used immediately before or after coronary artery bypass graft (CABG) surgery.
  • Gastrointestinal Risk: Celix-200 increases the risk of serious gastrointestinal adverse events, including bleeding, ulceration, and perforation of the stomach or intestines, which can occur without warning and may be fatal.

Other serious side effects can include allergic reactions (like swelling of the face, lips, or throat), severe skin reactions, kidney or liver problems, and fluid retention (edema). Patients should seek immediate medical attention if they experience symptoms such as chest pain, sudden weakness, shortness of breath, black or tarry stools, or yellowing of the skin or eyes.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information describes the manifestations and required actions in the event of an overdose with Celix-200 (celecoxib). Overdose presentations are typically limited to reversible symptoms such as drowsiness, nausea, vomiting, and epigastric pain.

However, severe outcomes documented in the context of acute nonsteroidal anti-inflammatory drug (NSAID) overdose may include gastrointestinal bleeding, acute renal failure, hypertension, respiratory depression, and coma. Anaphylactoid reactions are also a potential severe outcome.

Immediate medical attention is required for any severe signs. Regulators mandate that emergency services must be called immediately if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Contacting the poison control helpline is also a required action.

Management of a Celix-200 overdose is strictly symptomatic and supportive, as no specific antidote is known. Procedural steps may involve administering activated charcoal and an osmotic cathartic; this intervention is noted as beneficial only if performed within four hours of a large overdose. Due to the drug's high plasma protein binding, dialysis is unlikely to be useful for clearance.

Therapeutic Uses of Celix-200

Celix-200 is applied across domains where additional symptomatic support is needed, primarily focusing on easing the burden of symptoms related to inflammatory or irritative states that interfere with daily functioning. The active component is generally used to relieve symptoms associated with various inflammatory and painful conditions.

What Celix-200 Helps Manage

The medication is commonly used across conditions presenting with acute episodes and those characterized by periods of heightened symptoms. It is relevant for easing symptoms linked to chronic arthritis conditions—including Osteoarthritis (OA), Rheumatoid Arthritis (RA), and Ankylosing Spondylitis (AS)—as well as Juvenile Rheumatoid Arthritis (JRA) in children aged two and older. Celix-200 also plays a role in managing symptoms that appear suddenly or fluctuate, such as post-surgical discomfort and the severe discomfort associated with primary dysmenorrhea (menstrual cramps). It may also be part of symptomatic management in patients diagnosed with Familial Adenomatous Polyposis (FAP).

The overall benefit is generally linked to helping patients cope with physical manifestations. The medication's role is to support the patient during difficult episodes by easing distress and contributing to improved comfort during symptomatic periods. This support helps address symptom clusters that may become intense or disruptive, assisting with the goal of preserving functional stability when symptoms interfere with routine activities.


Quick Fact: Symptomatic relief for Joint Pain and Stiffness

Regulatory References

  1. MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Celix-200?

Celix-200 (celecoxib) eligibility is strictly defined by regulatory bodies based on a patient's medical history and current physiological status.

Population Status Official Regulatory Rule
Contraindicated (Must Not Use) Patients with known allergy to sulfonamides or a history of allergic reactions to aspirin or other NSAIDs. Use is prohibited for pain related to Coronary Artery Bypass Graft (CABG) surgery. Contraindicated in active gastrointestinal bleeding/ulceration, severe hepatic impairment (Child-Pugh C), or severe renal insufficiency (CrCl < 30 mL/min).
Approved Use Approved for use in adults for all labeled conditions. Approved for pediatric patients aged 2 years and older for Juvenile Rheumatoid Arthritis. Safety and efficacy are not established in children under 2 years of age.
Conditional Use (Requires Special Consideration) Reduced dosage is required for patients with moderate hepatic impairment (Child-Pugh B) and individuals identified as CYP2C9 poor metabolizers. Use is prohibited from 30 weeks of pregnancy and limited between 20 and 30 weeks gestation. Use during lactation is permitted with caution.

This profile establishes absolute exclusions for high-risk surgical settings and specific allergic or organ failure states. Conditional use rules mandate dose adjustments for metabolic differences and compromise to liver function. Eligibility is granted to adults and certain pediatric groups, while use is generally not recommended in the late stages of pregnancy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Celix-200 (celecoxib) is documented across three primary domains: drug metabolism, pharmacodynamic effects, and systemic exposure modification. Metabolic interactions occur because Celix-200 is principally metabolized by the CYP2C9 enzyme pathway. Co-administration with strong CYP2C9 inhibitors, such as Fluconazole, officially increases the systemic plasma concentrations of Celix-200. Conversely, co-administration with strong inducers like Rifampin may lead to reduced Celix-200 exposure. Furthermore, Celix-200 is also a moderate inhibitor of the CYP2D6 enzyme, which may increase the exposure of medications metabolized by that pathway.

Pharmacodynamic interactions center on additive risks. Combining Celix-200 with Warfarin or SSRIs/SNRIs is documented to increase the risk of serious bleeding events. Co-administration with other NSAIDs is generally not recommended due to increased gastrointestinal toxicity. Celix-200 may also officially diminish the blood pressure effects of ACE inhibitors, ARBs, and Diuretics.

Regarding systemic exposure, Celix-200 can increase the plasma concentrations of Lithium and Digoxin. Antacids containing aluminum and magnesium can reduce the total absorption of Celix-200. For administration timing, Celix-200 can be taken without regard to meals at the 200 mg twice-daily dose. The regulatory label formally contraindicates the use of Celix-200 for treating peri-operative pain in the setting of CABG surgery.

Mechanism of Action

The Mechanism of Selective COX-2 Inhibition

Celix-200 exerts its primary effect by acting as a highly selective inhibitor of the Cyclooxygenase-2 (COX-2) enzyme. This enzyme is preferentially upregulated in biological systems during injury, where its function is to convert arachidonic acid into pro-inflammatory signaling molecules. By binding to a specific internal pocket in the COX-2 structure, the compound structurally prevents this conversion, interrupting an early step in the inflammatory cascade.

Disrupting the Prostaglandin Synthesis Pathway

The consequence of selective COX-2 inhibition is a marked and targeted limitation of the synthesis of inflammatory mediators, specifically prostaglandin E2 (PGE2). This disruption modulates heightened pathway activation, resulting in the regulation of systems where excessive chemical signaling dominates. The mechanism operates by restricting the creation of these potent lipid messengers.

The Consequence: Reduction of Nociceptor Sensitization

The overall physiological effect of reduced PGE2 concentration is two-fold: it decreases the local vascular and cellular components of the inflammatory response, and it leads to the desensitization of peripheral nociceptors (sensory neurons). By decreasing the chemical excitability of these nerves, the mechanism restricts the effect of dysregulated inflammatory mediators, contributing to altered dynamics within targeted signaling pathways.

Dosage and Administration Information

How to use Celix-200 — Administration Guidelines

Celix-200 is administered via the oral route as a capsule. Guidelines emphasize using the lowest effective dosage for the shortest duration consistent with individual treatment goals. The capsule can generally be taken with or without food.

Dosing and Frequency

Condition Typical Adult Dosing (Maximum Daily Dose: 400 mg) Administration Notes
Osteoarthritis (OA) 200 mg once daily, or 100 mg twice daily. Can be taken regardless of meal timing.
Rheumatoid Arthritis (RA) 100 mg to 200 mg twice daily.
Ankylosing Spondylitis (AS) 200 mg once daily or 100 mg twice daily. A trial of 400 mg daily may be considered if no effect after 6 weeks.
Acute Pain/Primary Dysmenorrhea 400 mg initially, then an additional 200 mg if needed on Day 1. Subsequent days: 200 mg twice daily as needed. Use as needed, not for preventative treatment.

Special Administration Rules

  • Pediatric Use (Juvenile Rheumatoid Arthritis): Dosing for patients aged 2 years and older is weight-based: 50 mg twice daily for those greater than or equal to 10 kg to less than or equal to 25 kg, and 100 mg twice daily for those > 25 kg.
  • Difficulty Swallowing: If the capsule cannot be swallowed whole, the entire contents may be carefully emptied onto a level teaspoon of cool or room temperature applesauce and immediately ingested with 240 mL (8 oz) of water.
  • Dose Modification: A 50% dose reduction is recommended for patients with moderate hepatic impairment (Child-Pugh Class B) and in adult patients known or suspected to be poor CYP2C9 metabolizers.
  • Missed Dose: If a dose is missed, take it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped; do not double the dose.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Celix-200

This section summarizes the key clinical evaluations, including the types of studies and the outcomes they were designed to measure, as reported in authoritative governmental and peer-reviewed sources.


Evidence for Symptom Management in Chronic Arthritis

The evidence base for conditions characterized by fluctuating or episodic manifestations such as Osteoarthritis (OA) and Rheumatoid Arthritis (RA) contains data from multiple Randomized Controlled Trials (RCTs) and systematic reviews. Research explored how symptoms change over time in patients with chronic arthritis, relative to both placebo and other studied treatments.

Research primarily examined outcomes related to physical discomfort, such as pain intensity scales, and outcomes reflecting daily functioning or activity level, measured by standardized scales like the WOMAC index. Research examined these outcomes related to physical discomfort over study periods typically lasting between 6 and 24 weeks.

While the evidence for short-term symptomatic effects was observed in multiple large studies, data for certain groups remain insufficient, and the longest duration of follow-up for measuring functional outcomes alone is limited.


Evidence for Research into Acute Pain Relief

Celix-200 was evaluated in multiple short-term, placebo-controlled RCTs relevant in trials assessing short-term or episodic symptom patterns. These studies focused on managing acute, self-limiting pain, such as Post-Surgical Discomfort and severe discomfort associated with Primary Dysmenorrhea (menstrual cramps).

Research explored outcomes related to episodic or acute changes, primarily focusing on measurements of symptom intensity or variability. Studies monitored the time to onset of patient-reported changes in their pain level and how often they needed rescue pain medication over defined, brief time intervals. These findings describe patterns observed in the studies, suggesting that the medicine was observed in research contexts involving fluctuating or unstable acute symptoms.


Study Consistency and Evidence Gaps

The evidence base is well-defined for research exploring how symptoms change over time in major adult arthritic conditions (OA and RA) and for acute pain, where the findings indicate patterns related to what was observed relative to placebo. However, evidence quality varies across studies, and limitations exist across the entire body of work.

One significant limitation is the lack of information for long-term outcomes, as many efficacy trials used short follow-up durations. Additionally, regulatory bodies concluded that the evidence for Familial Adenomatous Polyposis (FAP) was limited, and the necessary long-term research to confirm the benefit was lacking, leading to the withdrawal of that authorization in some regions. Study results reflect the specific conditions under which they were conducted and research does not determine whether an individual will respond similarly.

Key Studies & References

  1. Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION): A cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis

Frequently Asked Questions (FAQ)

Common questions about Celix-200 (FAQ)


Q: Is it common for people to feel tired when taking Celix-200?

Fatigue or excessive tiredness may occur, but official product information describes these as unusual. However, regulatory documents also list tiredness as a potential sign of serious adverse events like heart failure or anemia. If symptoms are persistent or severe, it is appropriate to consult with a medical professional.


Q: Do older adults react differently to Celix-200?

Official product information indicates that adults age 65 and older may be more likely to experience certain serious adverse events. These can include gastrointestinal bleeding, kidney problems, and cardiac events. Regulatory information highlights the need for careful consideration when used in the older adult population.


Q: Does the medicine need time to build up in the body to work best?

According to official pharmacokinetic information, the drug generally reaches steady state conditions—meaning a consistent level in the bloodstream—on or before Day 5 of taking multiple doses. This indicates the point when the drug concentration is expected to become relatively consistent in the body.


Q: Are the side effects of Celix-200 temporary or long-lasting?

Studies and official information indicate that milder side effects, such as headache or dizziness, often lessen or go away within the first few days or weeks of treatment as the body adjusts. However, if any side effects become severe, persistent, or worrisome, a consultation with a medical professional would be appropriate.


Q: Can Celix-200 cause changes in mood or anxiety?

Regulatory/medical information sources have listed anxiety as a potential symptom associated with certain serious side effects. If you notice changes in your mood or anxiety levels, it may be helpful to discuss this with a medical professional.


Q: Can taking Celix-200 cause sun sensitivity?

While severe skin reactions are listed as a risk in official documents, photosensitivity (increased sensitivity to the sun) is sometimes mentioned in safety reviews as a known potential effect of the NSAID class of medicines.


Q: How does Celix-200 interact with alcohol?

Combining Celix-200 with alcohol is described in official sources as raising the risk of serious side effects. Specifically, this combination can increase the risk of stomach bleeding and other gastrointestinal adverse events.


Q: Is it true that Celix-200 can change laboratory test results?

Yes, according to official information, Celix-200 can influence certain lab test results. This may include causing elevated liver enzymes or leading to a higher-than-normal level of potassium in the blood, a condition known as hyperkalemia.


Q: How long after stopping Celix-200 does it stay in your system?

Official pharmacokinetic information states that the medicine has an effective half-life of approximately 11 hours. This means it takes about 11 hours for the amount of Celix-200 in the body to be reduced by half. Elimination typically occurs over a period equivalent to several half-lives.


Q: What happens if I accidentally take more Celix-200 than prescribed?

Official patient counseling information states that in cases of accidental overdose, one should contact a poison control center or seek emergency medical help immediately. This is the general procedure recommended for managing over-exposure to the medication.


Q: How quickly does Celix-200 start working for most people?

Studies indicate that for conditions like acute pain or flare-ups of Osteoarthritis, the medicine was shown to provide a significant reduction of pain symptoms within 24 to 48 hours of starting the dose.


Q: Is Celix-200 known to cause weight gain?

While Celix-200 is not directly listed as a common cause of weight gain, official safety information lists unexplained weight gain as a symptom of fluid retention (edema) and potential heart failure. Both fluid retention and heart failure are serious risks associated with this type of medicine.


Q: What foods or supplements are known to interact with Celix-200?

Official information states that antacids containing aluminum and magnesium can reduce the amount of the drug absorbed by the body. Celix-200 also interacts with certain liver enzyme pathways (CYP2C9 and CYP2D6) that metabolize other drugs and supplements.


Q: Is Celix-200 considered a high-risk medication?

Official regulatory documents include a Boxed Warning that highlights the increased risk of serious cardiovascular events, such as heart attack and stroke. The warning also addresses the risk of serious gastrointestinal events, including bleeding and ulceration. The presence of this warning means that a careful evaluation of the potential risks is highly warranted before use.


Q: What is the significance of the '-200' in the drug name?

The number 200 in the drug name likely reflects that 200 mg is a common primary capsule strength, and in many cases, is the maximum recommended daily dose for conditions like Osteoarthritis.


Q: Is there a generic version of Celix-200 available?

Yes, regulatory approval documents and information from sources like the FDA confirm that the active ingredient, celecoxib, is available as a generic prescription product.


Q: Why is Celix-200 sometimes prescribed for more than one condition?

Official regulatory sources indicate that the drug's mechanism involves inhibiting the COX-2 enzyme, which effectively interrupts the body's generalized inflammatory cascade. Because inflammation and pain contribute to multiple conditions, this single mechanism allows the drug to be used for a variety of approved inflammatory and acute pain conditions.


Q: Are there specific official warnings about driving or operating machinery while taking Celix-200?

Official product information does not issue a general prohibition, but it lists side effects such as dizziness. Since these effects could impair your ability to safely drive or operate heavy machinery, it is important to be cautious.


Q: What types of long-term studies have been done on Celix-200?

The clinical trials supporting the initial evidence for chronic conditions typically had a defined duration. Studies for Osteoarthritis often lasted up to 12 weeks, while those for Rheumatoid Arthritis generally ran up to 24 weeks.


Q: Is Celix-200 safe for women who might become pregnant?

Official product information notes that NSAID-class medications may be associated with reversible infertility in women. The label advises that if a woman is having difficulty conceiving, the discontinuation of the drug should be considered.


Q: What is the expected duration of treatment with Celix-200?

Regulatory guidance emphasizes that the medication should be used at the lowest effective dose for the shortest duration that aligns with individual treatment goals. For acute pain, use is typically on an as-needed basis, while chronic conditions involve longer, but carefully managed, courses.


Q: What are the less common, but serious side effects of Celix-200?

In addition to the serious risks highlighted in the Boxed Warning (cardiovascular and gastrointestinal events), official information lists other serious potential side effects. These include severe skin reactions, as well as potential liver problems and renal toxicity (kidney damage).


Q: Can Celix-200 be taken with common cold and flu medications?

Regulatory warnings advise against taking Celix-200 with other NSAIDs because of an increased risk of gastrointestinal toxicity. Since many over-the-counter cold and flu medications contain NSAIDs, it is important that the ingredients of these products are checked.


Q: What happens if Celix-200 is not stored at the correct temperature?

Official storage requirements mandate that Celix-200 be stored at Controlled Room Temperature and protected from moisture and light. Following these instructions is necessary to ensure the product quality and effectiveness are maintained throughout its shelf-life.


Q: What should I do if the medicine does not seem to be working after the expected time?

Official product information notes that for certain conditions, such as Ankylosing Spondylitis, a lack of effect after a specific trial period (e.g., 6 weeks on a certain dose) suggests that a positive response is unlikely. In such cases, consulting a medical professional is advised to consider alternative treatment options.


Q: What clinical trials have defined the initial use of Celix-200?

The initial uses of Celix-200 were defined by a series of placebo- and active-controlled clinical trials. These studies established the evidence base for conditions like Osteoarthritis (trials typically up to 12 weeks) and Rheumatoid Arthritis (trials typically up to 24 weeks).


How should Celix-200 be stored and disposed of?

How to Store and Dispose of Celix-200 (Celecoxib Capsules)

Celix-200 capsules must be stored at Controlled Room Temperature (CRT), which is 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C. Storage requires protection from both moisture and light, and the medication must be kept in a closed container.

Handling and Child Safety

The product must be kept out of the reach of children. If the capsule contents are mixed with applesauce, rice gruel, or yogurt, the mixture can be stored under refrigeration for up to six hours, but contents mixed with mashed banana must be ingested immediately.

Disposal Requirements

Unused or expired Celix-200 must not be disposed of in household trash or poured into wastewater. Disposal must be carried out in accordance with local requirements and regulations after consulting a pharmacist or local waste disposal company.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Celix-200 found in:

A-Z Index: